Growth Metrics

Ultragenyx Pharmaceutical (RARE) Amortizatization of Intangibles (2016 - 2025)

Ultragenyx Pharmaceutical has reported Amortizatization of Intangibles over the past 10 years, most recently at $516000.0 for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 83.78% to $516000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, down 69.23% year-over-year, with the annual reading at $4.0 million for FY2025, 69.23% down from the prior year.
  • Amortizatization of Intangibles was $516000.0 for Q4 2025 at Ultragenyx Pharmaceutical, down from $704000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $4.1 million in Q4 2023 and troughed at -$2.1 million in Q4 2021.
  • The 5-year median for Amortizatization of Intangibles is $1.3 million (2022), against an average of $1.0 million.
  • Year-over-year, Amortizatization of Intangibles tumbled 947.33% in 2021 and then soared 376.68% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$2.1 million in 2021, then soared by 178.31% to $1.6 million in 2022, then skyrocketed by 148.85% to $4.1 million in 2023, then fell by 22.5% to $3.2 million in 2024, then tumbled by 83.78% to $516000.0 in 2025.
  • Per Business Quant, the three most recent readings for RARE's Amortizatization of Intangibles are $516000.0 (Q4 2025), $704000.0 (Q3 2025), and $1.0 million (Q2 2025).